| Christopher E Heise; Michael Friedrich Thomas Koehler; Jeremy Mark Murray; Peter Andrew Smith (2020). PEPTIDIC ANTIBIOTIC COMPLEXES AND THEIR METHODS OF USE. Patent Number: MA50664A. |
|
Patent |
|
| James Philip O'CONNELL; John Robert Porter; Alastair Lawson; Boris Kroeplien; Stephen Edward Rapecki et al. (2021). Mechanism of action. Patent Number: US20210140972A1. |
|
Patent |
|
| Guo Shuaiqi; Voets Ilja; Davies Peter; Klose Karl (2021). Peptides for use in the treatment of cholera. Patent Number: NL2023527B1. |
|
Patent |
|
| Mark Anderson; Debra Chao; Enrico L. Digiammarino; David A. Egan; Chung-Ming Hsieh et al. (2019). Prolactin receptor binding proteins and uses thereof. Patent Number: AU2019202725A1. |
|
Patent |
|
| Anish Suri; Steven Sheriff; Suzzanne Suchard; Yamniuk Aaron; Stanley Krystek et al. (2014). POLYPEPTIDES ANTIBODIES THAT ANTAGONIZE CD40. Patent Number: PE20141188A1. |
|
Patent |
|
| Peter Andrew Smith; Jeremy Mark MURRAY; Michael Friedrich Thomas KOEHLER; Christopher E. Heise (2020). Peptide antibiotic complexes and methods of use thereof. Patent Number: EP3688028A2. |
|
Patent |
|
| James Philip O'CONNELL; John Robert Porter; Alastair Lawson; Boris Kroeplien; Stephen Edward Rapecki et al. (2022). Method for identifying a modulator of the TNFα or CD40L interaction with their cognate receptors. Patent Number: US11448655B2. |
|
Patent |
|
| Folgueira Judit Anido; Teixidor Ester Bonfill; Johan Fransson; Garcia Monica Pascual; Rigol Ester Planas et al. (2021). COMBINATION OF LIF INHIBITORS AND PD-1 AXIS INHIBITORS FOR USE IN THE TREATMENT OF CANCER. Patent Number: MA52231A. |
|
Patent |
|
| Min-Jae Choi; Francisco Pelayo Garcia De Arquer; Sjoerd Hoogland; Edward Sargent (2021). Cascade surface modification of colloidal quantum dot inks enables efficient bulk homojunction photovoltaics. Patent Number: CA3104172A1. |
|
Patent |
|
| Mark Anderson; Debra Chao; Enrico L. Digiammarino; David A. Egan; Chung-Ming Hsieh et al. (2019). Prolactin receptor binding proteins and uses thereof. Patent Number: AU2013370548B2. |
|
Patent |
|
| J·赛瓦内苏阿雷斯; J·阿尼多福尔盖拉; P·A·吉布林; P·E·拜利斯; J·弗兰松 et al. (2021). Method for quantifying LIF and uses thereof. Patent Number: CN112654395A. |
|
Patent |
|
| A.苏里; S.舍里夫; S.苏查德; A.亚姆纽克; S.克里斯特克 et al. (2017). Antagonism CD40 antibody polypeptides. Patent Number: CN106977604A. |
|
Patent |
|
| スミス・ピーター・アンドリュー; マリー・ジェレミー・マーク; ケーラー・マイケル・フリードリヒ・トーマス; ハイゼ・クリストファー・イー (2020). Peptide antibiotic complex and how to use it. Patent Number: JP2020536072A. |
|
Patent |
|
| ジョアン・セオアネ・スアレス; Seoane Suarez Joan; ジュディット・アニド・フォルゲイラ; Anido Folgueira Judit; ヨハン・フランソン et al. (2024). Combination of LIF inhibitor and PD-1 axis inhibitor for use in the treatment of cancer - Patent Application 20100223333. Patent Number: JP2024054138A. |
|
Patent |
|
| フィリップ オコンネル、ジェームス; フィリップ オコンネル、ジェームス; ロバート ポーター、ジョン; ロバート ポーター、ジョン; ローソン、アレステア et al. (2020). Mechanism of action. Patent Number: JP6752344B2. |
|
Patent |
|